General
Preferred name
OPIPRAMOL
Synonyms
Opipramol dihydrochloride ()
G-33040 ()
Ensidon ()
G33040 ()
OPIPRAMOL HYDROCHLORIDE ()
NSC-169867 ()
Opipramol dura ()
Insidon ()
Opipramol hcl ()
P&D ID
PD013337
CAS
315-72-0
909-39-7
Tags
available
drug
drug candidate
Drug indication
Anxiety disorder
Dementia
Drug Status
approved
investigational
Max Phase
3.0
Probe control
Probe control not defined
Orthogonal probes
0
No orthogonal probes found
Similar probes
0
No structurally similar probes found
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
Description
(extracted from source data)
DESCRIPTION
Opipramol is an atypical tricyclic antidepressant (TCA) . It acts primarily as a sigma (σ) receptor agonist. Weak antiviral activity of opipramol dihydrochloride against SARS-CoV-2 (in Vero E6 cells; EC50 5 μM) was reported by Touret et al. .
(GtoPdb)
DESCRIPTION
Opipramol (Ensidon) is an atypical tricyclic antidepressant (TCA). Opipramol acts primarily as a sigma (¦Ò) receptor agonist and can potently interact with sigma recognition sites with a Ki value of 50 nM. Opipramol can be used for the research of generalized anxiety disorder (GAD)[1][2].
PRICE
189
DESCRIPTION
Opipramol (Ensidon) is a compound with antidepressant activity that attenuates cocaine-seeking behavior in a rat model of self-administration.Opipramol is a sigma (??) receptor agonist with anxiolytic activity and may be used in the study of neurological disorders.
DESCRIPTION
Opipramol is a medication to treat general anxiety and somatoform disorders. It inhibits sigma non-opioid intracellular receptor 1, Ki=0.2 nM.
(Enamine Bioactive Compounds)
DESCRIPTION
Opipramol (Ensidon) is a compound with antidepressant activity that attenuates cocaine-seeking behavior in a rat model of self-administration.Opipramol is a sigma (σ) receptor agonist with anxiolytic activity and may be used in the study of neurological disorders.
(TargetMol Bioactive Compound Library)
DESCRIPTION
sigma1, sigma2 receptor agonist; an antagonist at D2, 5HT2, and H1 receptors; atypical antidepressant, antipsychotic, and axiolytic.
(LOPAC library)
[[ p.pathway_name ]]
[[ compound.targets[tid].gene_name ]]
Cell lines
0
Organisms
2
Compound Sets
17
Cayman Chemical Bioactives
ChEMBL Drugs
Drug Repurposing Hub
DrugBank
DrugCentral
DrugCentral Approved Drugs
DrugMAP
DrugMAP Approved Drugs
DrugMatrix
Enamine Bioactive Compounds
Guide to Pharmacology
LOPAC library
MedChem Express Bioactive Compound Library
NPC Screening Collection
Prestwick Chemical Library
ReFrame library
TargetMol Bioactive Compound Library
[[ a.name ]]
[[ ligand_id ]]
free of charge
External IDs
68
Molecular Weight
363.23
Hydrogen Bond Acceptors
4
Hydrogen Bond Donors
1
Rotatable Bonds
6
Ring Count
4
Aromatic Ring Count
2
cLogP
3.31
TPSA
29.95
Fraction CSP3
0.39
Chiral centers
0.0
Largest ring
7.0
QED
0.85
Structural alerts
0
No structural alerts detected
Custom attributes
(extracted from source data)
Selectivity
1, 2
Target
Sigma Receptor
Indication
generalized anxiety disorder (GAD)
MOA
Sigma Receptor agonist
Pathway
Neuronal Signaling
GPCR/G protein
Source data

